SK10882002A3 - Heterocyklické amidové deriváty - Google Patents
Heterocyklické amidové deriváty Download PDFInfo
- Publication number
- SK10882002A3 SK10882002A3 SK1088-2002A SK10882002A SK10882002A3 SK 10882002 A3 SK10882002 A3 SK 10882002A3 SK 10882002 A SK10882002 A SK 10882002A SK 10882002 A3 SK10882002 A3 SK 10882002A3
- Authority
- SK
- Slovakia
- Prior art keywords
- alkyl
- carbon atoms
- moiety
- moieties
- optionally substituted
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/08—Antibacterial agents for leprosy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
- C07D241/38—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
- C07D241/40—Benzopyrazines
- C07D241/44—Benzopyrazines with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Virology (AREA)
- Pulmonology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Urology & Nephrology (AREA)
- Ophthalmology & Optometry (AREA)
- AIDS & HIV (AREA)
- Heart & Thoracic Surgery (AREA)
- Transplantation (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Vascular Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Cardiology (AREA)
- Molecular Biology (AREA)
- Psychiatry (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US18015900P | 2000-02-04 | 2000-02-04 | |
| PCT/IB2001/000107 WO2001057023A1 (en) | 2000-02-04 | 2001-01-26 | Heterocyclic amide derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SK10882002A3 true SK10882002A3 (sk) | 2003-10-07 |
Family
ID=22659425
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SK1088-2002A SK10882002A3 (sk) | 2000-02-04 | 2001-01-26 | Heterocyklické amidové deriváty |
Country Status (37)
| Country | Link |
|---|---|
| US (2) | US6548671B2 (es) |
| EP (1) | EP1252154A1 (es) |
| JP (1) | JP2003522164A (es) |
| KR (2) | KR20050009776A (es) |
| CN (1) | CN1398265A (es) |
| AP (1) | AP2002002595A0 (es) |
| AR (1) | AR027349A1 (es) |
| AU (1) | AU2699701A (es) |
| BG (1) | BG106922A (es) |
| BR (1) | BR0108002A (es) |
| CA (1) | CA2399214A1 (es) |
| CZ (1) | CZ20022542A3 (es) |
| EA (2) | EA005320B1 (es) |
| EE (1) | EE200200432A (es) |
| GE (1) | GEP20043301B (es) |
| GT (1) | GT200100021A (es) |
| HK (1) | HK1050006A1 (es) |
| HN (1) | HN2001000021A (es) |
| HR (1) | HRP20020638A2 (es) |
| HU (1) | HUP0204560A3 (es) |
| IL (1) | IL150862A0 (es) |
| IS (1) | IS6468A (es) |
| MA (1) | MA25653A1 (es) |
| NO (1) | NO20023675L (es) |
| NZ (1) | NZ520075A (es) |
| OA (1) | OA12174A (es) |
| PA (1) | PA8511401A1 (es) |
| PE (1) | PE20011057A1 (es) |
| PL (1) | PL357094A1 (es) |
| SK (1) | SK10882002A3 (es) |
| SV (1) | SV2002000302A (es) |
| TN (1) | TNSN01021A1 (es) |
| TW (1) | TW200804311A (es) |
| UA (1) | UA72789C2 (es) |
| UY (1) | UY26568A1 (es) |
| WO (1) | WO2001057023A1 (es) |
| ZA (1) | ZA200206140B (es) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003043997A1 (en) * | 2001-11-15 | 2003-05-30 | Eli Lilly And Company | Peroxisome proliferator activated receptor alpha agonists |
| SE0201980D0 (sv) * | 2002-06-24 | 2002-06-24 | Astrazeneca Ab | Novel compounds |
| US20040087571A1 (en) * | 2002-10-30 | 2004-05-06 | Pfizer Inc | Methods of using CCR1 antagonists as immunomodulatory agents |
| US20040097554A1 (en) * | 2002-10-30 | 2004-05-20 | Pfizer Inc | Heteroaryl-hexanoic acid amide derivatives as immonomodulatory agents |
| EP1948657A1 (en) | 2005-11-15 | 2008-07-30 | Vertex Pharmaceuticals Incorporated | Azaindazoles useful as inhibitors of kinases |
| CN1971279B (zh) * | 2006-12-06 | 2011-05-18 | 华中农业大学 | 喹噁啉-2-羧酸残留的酶联免疫检测方法及试剂盒 |
| PL3609868T3 (pl) | 2017-03-13 | 2024-04-02 | Raqualia Pharma Inc. | Pochodne tetrahydrochinoliny jako antagoniści receptora P2X7 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL88619A0 (en) * | 1987-12-15 | 1989-07-31 | Pfizer | Non-peptidic renin inhibitors |
| EP0374098A3 (de) * | 1988-12-15 | 1991-05-02 | Ciba-Geigy Ag | Retrovirale Proteasehemmer |
| JPH06510766A (ja) | 1991-09-11 | 1994-12-01 | スミスクライン・ビーチャム・コーポレイション | Ｈ．ｉ．ｖ．阻害剤としてのヘテロ環含有ペプチド同配体 |
| JPH07504417A (ja) * | 1992-02-26 | 1995-05-18 | スミスクライン・ビーチャム・コーポレイション | レトロウイルスプロテアーゼ拮抗薬 |
| EP0708085B1 (en) * | 1994-10-19 | 2002-07-17 | Novartis AG | Antiviral ethers of aspartate protease substrate isosteres |
| US6403587B1 (en) * | 1997-02-26 | 2002-06-11 | Pfizer Inc. | Heteroaryl-hexanoic acid amide derivatives, their preparation and their use as selective inhibitors of MIP-1-α binding to its CCR 1 receptor |
| SK11262000A3 (sk) * | 1998-02-05 | 2001-01-18 | Pfizer Products Inc. | Deriváty dihydroxyhexánovej kyseliny a farmaceutický prostriedok,ktorý ich obsahuje |
-
2001
- 2001-01-26 NZ NZ520075A patent/NZ520075A/en unknown
- 2001-01-26 AU AU26997/01A patent/AU2699701A/en not_active Abandoned
- 2001-01-26 KR KR10-2005-7000487A patent/KR20050009776A/ko not_active Application Discontinuation
- 2001-01-26 EA EA200200749A patent/EA005320B1/ru not_active IP Right Cessation
- 2001-01-26 HU HU0204560A patent/HUP0204560A3/hu unknown
- 2001-01-26 WO PCT/IB2001/000107 patent/WO2001057023A1/en not_active Application Discontinuation
- 2001-01-26 GE GE4875A patent/GEP20043301B/en unknown
- 2001-01-26 EP EP01901328A patent/EP1252154A1/en not_active Withdrawn
- 2001-01-26 UA UA2002086471A patent/UA72789C2/uk unknown
- 2001-01-26 SK SK1088-2002A patent/SK10882002A3/sk not_active Application Discontinuation
- 2001-01-26 BR BR0108002-4A patent/BR0108002A/pt not_active IP Right Cessation
- 2001-01-26 IL IL15086201A patent/IL150862A0/xx unknown
- 2001-01-26 CN CN01804508A patent/CN1398265A/zh active Pending
- 2001-01-26 JP JP2001557855A patent/JP2003522164A/ja not_active Withdrawn
- 2001-01-26 CA CA002399214A patent/CA2399214A1/en not_active Abandoned
- 2001-01-26 CZ CZ20022542A patent/CZ20022542A3/cs unknown
- 2001-01-26 OA OA1200200235A patent/OA12174A/en unknown
- 2001-01-26 AP APAP/P/2002/002595A patent/AP2002002595A0/en unknown
- 2001-01-26 EA EA200401099A patent/EA200401099A1/ru unknown
- 2001-01-26 KR KR1020027010005A patent/KR20020072304A/ko not_active Application Discontinuation
- 2001-01-26 EE EEP200200432A patent/EE200200432A/xx unknown
- 2001-01-26 PL PL01357094A patent/PL357094A1/xx not_active Application Discontinuation
- 2001-01-30 TW TW093137061A patent/TW200804311A/zh unknown
- 2001-01-30 PE PE2001000102A patent/PE20011057A1/es not_active Application Discontinuation
- 2001-01-31 GT GT200100021A patent/GT200100021A/es unknown
- 2001-01-31 HN HN2001000021A patent/HN2001000021A/es unknown
- 2001-01-31 US US09/774,871 patent/US6548671B2/en not_active Expired - Fee Related
- 2001-01-31 UY UY26568A patent/UY26568A1/es not_active Application Discontinuation
- 2001-02-01 AR ARP010100483A patent/AR027349A1/es unknown
- 2001-02-02 SV SV2001000302A patent/SV2002000302A/es not_active Application Discontinuation
- 2001-02-02 TN TNTNSN01021A patent/TNSN01021A1/fr unknown
- 2001-02-05 PA PA20018511401A patent/PA8511401A1/es unknown
-
2002
- 2002-07-11 IS IS6468A patent/IS6468A/is unknown
- 2002-07-15 BG BG106922A patent/BG106922A/xx unknown
- 2002-07-26 HR HRP20020638 patent/HRP20020638A2/hr not_active Application Discontinuation
- 2002-08-01 MA MA26757A patent/MA25653A1/fr unknown
- 2002-08-01 ZA ZA200206140A patent/ZA200206140B/xx unknown
- 2002-08-02 NO NO20023675A patent/NO20023675L/no not_active Application Discontinuation
-
2003
- 2003-02-06 US US10/360,059 patent/US6689886B2/en not_active Expired - Fee Related
- 2003-03-28 HK HK03102236.7A patent/HK1050006A1/zh unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5804588A (en) | Quinoline carboxanides and their therapeutic use | |
| US20060247439A1 (en) | Mchir antagonists | |
| US20050026916A1 (en) | Heterocyclic compounds as P2X7 ion channel blockers | |
| US20100317607A1 (en) | Use of compounds for preparing anti-tuberculosis agents | |
| SK112899A3 (en) | Heteroaryl-hexanoic acid amide derivatives, their preparation and their use as selective inhibitors of mip-1-alpha binding to its ccr1 receptor | |
| JP2002524512A (ja) | ｃＧＭＰホスホジエステラーゼの縮合ピリジン阻害剤 | |
| JP2005537247A (ja) | 置換されたキノリンｃｃｒ５受容体アンタゴニスト | |
| US7176313B2 (en) | Anti acid-fast bacterial agent containing pyridonecarboxylic acids as active ingredient | |
| US6958349B2 (en) | Heteroaryl alkylamide derivatives useful as bradykinin receptor modulators | |
| CN107200734B (zh) | 奎宁环衍生物及其制备方法和用途 | |
| SK11262000A3 (sk) | Deriváty dihydroxyhexánovej kyseliny a farmaceutický prostriedok,ktorý ich obsahuje | |
| SK10882002A3 (sk) | Heterocyklické amidové deriváty | |
| US5281613A (en) | Heterocyclic compounds | |
| WO2004103974A1 (ja) | 置換２－オキソキノリン化合物およびその医薬用途 | |
| KR970005298B1 (ko) | 퀴놀린계 유도체와 그의 제조방법 | |
| AU2007328889A1 (en) | Antibacterial quinoline derivatives | |
| DE10318610A1 (de) | 7-Azaindole und deren Verwendung als Therapeutika | |
| US20040087571A1 (en) | Methods of using CCR1 antagonists as immunomodulatory agents | |
| WO1995021831A1 (en) | Pharmaceutical piperazine compounds | |
| EP1498417A1 (en) | Heterocyclic amide derivatives | |
| CZ9902904A3 (cs) | Deriváty amidů heteroarylhexanových kyselin, farmaceutické kompozice na jejich bázi a způsoby léčení nebo prevence | |
| MXPA98009740A (es) | Carboxamidas de quinolina como inhibidores de fnt y como inhibidores de fde-iv |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC9A | Refused patent application |